Lasse Skafte Vestergaard

Lasse Skafte Vestergaard

Kontakt

Lasse Skafte Vestergaard, Overlæge, Infektionsepidemiologi og Forebyggelse / Vaccineforebyggelige sygdomme
T. 32689077 @. lav@ssi.dk

Ansvarsområder

Teamleder for emerging infections, nationalt ansvarlig for epidemiologisk overvågning og rapportering af vektor-bårne infektioner og zoonotisk influenza, overvågning af overdødelighed igennem EuroMOMO, udarbejdelse af danske anbefalinger for rejsevaccination og malariaprofylakse, SSI’s repræsentant i myndighedsgruppen for koordination af zoonoser (KOZO), uddannelsesansvarlig overlæge (UAO) for samfundsmedicin på SSI, medlem af ECDC’s koordinationskomite for emerging vector-borne diseases (EVD), medlem af Technical Review Panel (TRP), The Global Fund to Fight Aids, Tuberculosis and Malaria, konsulent for WHO.

Forskningsområder

Infektionsepidemiologi. Kontrol og elimination af malaria. Vektorbårne infektioner. Alvorlige luftvejsinfektioner. Overdødelighed i forbindelse med epidemier og hedebølger. Klimaforandringernes konsekvenser for sundhed.

PubMed link

Lasse Skafte Vestergaard

Udvalgte publikationer

Bager P, Svalgaard IB, Lomholt FK, Emborg HD, Christiansen LE, Soborg B, Hviid A, Vestergaard LS. The hospital and mortality burden of COVID-19 compared with influenza in Denmark: a national observational cohort study, 2022-24. Lancet Infectious Diseases. 2025 Jan 29:S1473-3099(24)00806-5.

Nørgaard SK, Nielsen J, Nordholm AC, Richter L, Chalupka A, Sierra NB, Braeye T, Athanasiadou M, Lytras T, Denissov G, Luomala O, Fouillet A, Pontais I, An der Heiden M, Zacher B, Weigel A, Foppa I, Gkolfinopoulou K, Panagoulias I, Paldy A, Malnasi T, Domegan L, Kelly E, Rotem N, Rakhlin O, de'Donato FK, Di Blasi C, Hoffmann P, Velez T, England K, Calleja N, van Asten L, Jongenotter F, Rodrigues AP, Silva S, Klepac P, Gomez-Barroso D, Gomez IL, Galanis I, Farah A, Weitkunat R, Fehst K, Andrews N, Clare T, Bradley DT, O'Doherty MG, William N, Hamilton M, Søborg B, Krause TG, Bundle N, Vestergaard LS. Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024. Eurosurveillance. 2024 Apr;29(15):2400178.

Vestergaard LS, Pebody RG. Understanding excess mortality in Europe during the COVID-19 pandemic. Lancet Regional Health Europe. 2024 Aug 30;45:101053.

Lomholt FK, Emborg HD, Nørgaard SK, Nielsen J, Munkstrup C, Møller KL, Krog JS, Trebbien R, Vestergaard LS. Resurgence of Respiratory Syncytial Virus in the Summer of 2021 in Denmark-a Large out-of-season Epidemic Affecting Older Children. Open Forum Infectious Diseases. 2024 Feb 5;11(3):ofae069.

Munkstrup C, Lomholt FK, Emborg HD, Møller KL, Krog JS, Trebbien R, Vestergaard LS. Early and intense epidemic of respiratory syncytial virus (RSV) in Denmark, August to December 2022. Eurosurveillance. 2023 Jan;28(1):2200937.

Friis NU, Martin-Bertelsen T, Pedersen RK, Nielsen J, Krause TG, Andreasen V, Vestergaard LS. COVID-19 mortality attenuated during widespread Omicron transmission, Denmark, 2020 to 2022https://pubmed.ncbi.nlm.nih.gov/36695485/. Eurosurveillance. 2023 Jan;28(3):2200547.

Nygaard U, Hartling UB, Nielsen J, Vestergaard LS, Dungu KHS, Nielsen JSA, Sellmer A, Matthesen AT, Kristensen K, Holm M. Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID-19 pandemic: a Danish nationwide cohort study. Lancet Child Adolescent Health. 2023 Mar;7(3):171-179.

Vestergaard LS, Nielsen J, Richter L, Schmid D, Bustos N, Braeye T, Denissov G, Veideman T, Luomala O, Möttönen T, Fouillet A, Caserio-Schönemann C, An der Heiden M, Uphoff H, Lytras T, Gkolfinopoulou K, Paldy A, Domegan L, O'Donnell J, De' Donato F, Noccioli F, Hoffmann P, Velez T, England K, van Asten L, White RA, Tønnessen R, da Silva SP, Rodrigues AP, Larrauri A, Delgado-Sanz C, Farah A, Galanis I, Junker C, Perisa D, Sinnathamby M, Andrews N, O'Doherty M, Marquess DF, Kennedy S, Olsen SJ, Pebody R; ECDC Public Health Emergency Team for COVID-19; Krause TG, Mølbak K. Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020. Eurosurveillance. 2020 Jul;25(26):2001214.

Hartmeyer GN, Stensvold CR, Fabricius T, Marmolin ES, Hoegh SV, Nielsen HV, Kemp M, Vestergaard LS. Plasmodium cynomolgi as cause of malaria in tourist to Southeast Asia, 2018. Emerging Infectious Disease. 2019 Oct;25(10):1936-1939.

Hopkins H, Bruxvoort KJ, Cairns ME, Chandler CI, Leurent B, Ansah EK, Baiden F, Baltzell KA, Björkman A, Burchett HE, Clarke SE, DiLiberto DD, Elfving K, Goodman C, Hansen KS, Kachur SP, Lal S, Lalloo DG, Leslie T, Magnussen P, Jefferies LM, Mårtensson A, Mayan I, Mbonye AK, Msellem MI, Onwujekwe OE, Owusu-Agyei S, Reyburn H, Rowland MW, Shakely D, Vestergaard LS, Webster J, Wiseman VL, Yeung S, Schellenberg D, Staedke SG, Whitty CJ. Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: analysis of observational and randomised studies in public and private healthcare settings. BMJ. 2017 Mar 29;356:j1054.

McEwen J, Vestergaard LS, Sanburg AL. Pacific Island Pharmacovigilance: The Need for a Different Approach. Drug Safety. 2016 Oct;39(10):891-4.

Aumentado C, Cerro BR, Olobia L, Suy LL, Reyes A, Kusumawathie PH, Sagrado M, Hall JL, Abeyasinghe R, Foxwell AR, Vestergaard LS. The prevention and control of dengue after Typhoon Haiyan. Western Pacific Surveillance Response Journal. 2015 Nov 6;6 Suppl 1(Suppl 1):60-5.

Mitjà O, Marks M, Konan DJ, Ayelo G, Gonzalez-Beiras C, Boua B, Houinei W, Kobara Y, Tabah EN, Nsiire A, Obvala D, Taleo F, Djupuri R, Zaixing Z, Utzinger J, Vestergaard LS, Bassat Q, Asiedu K. Global epidemiology of yaws: a systematic review. Lancet Global Health. 2015 Jun;3(6):e324-31.

Kelly GC, Hale E, Donald W, Batarii W, Bugoro H, Nausien J, Smale J, Palmer K, Bobogare A, Taleo G, Vallely A, Tanner M, Vestergaard LS, Clements AC. A high-resolution geospatial surveillance-response system for malaria elimination in Solomon Islands and Vanuatu. Malaria Journal. 2013 Mar 21;12:108.

Mmbando BP, Vestergaard LS, Kitua AY, Lemnge MM, Theander TG, Lusingu JP. A progressive declining in the burden of malaria in north-eastern Tanzania. Malaria Journal. 2010 Jul 23;9:216.

Haissman JM, Vestergaard LS, Sembuche S, Erikstrup C, Mmbando B, Mtullu S, Lemnge MM, Gerstoft J, Ullum H. Plasma cytokine levels in Tanzanian HIV-1-infected adults and the effect of antiretroviral treatment. Journal of Acquired Immune Deficiency Syndrome. 2009 Dec 1;52(4):493-7.

Vestergaard LS, Lusingu JP, Nielsen MA, Mmbando BP, Dodoo D, Akanmori BD, Alifrangis M, Bygbjerg IC, Lemnge MM, Staalsoe T, Hviid L, Theander TG. Differences in human antibody reactivity to Plasmodium falciparum variant surface antigens are dependent on age and malaria transmission intensity in northeastern Tanzania.
Infection and Immunity. 2008 Jun;76(6):2706-14.

Vestergaard LS, Ringwald P. Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies. American Journal of Tropical Medicine and Hygiene. 2007 Dec;77(6 Suppl):153-9.